NCT00261118View on ClinicalTrials.gov

Rituximab in Active Ulcerative Colitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2009

Study Completion Date

October 31, 2009

Conditions
Ulcerative Colitis
Interventions
DRUG

Rituximab

Rituximab 1g in 500 mls Normal Saline Placebo 500 mls Normal Saline

Trial Locations (1)

L7 8XP

Royal Liverpool University Hospital, Liverpool

All Listed Sponsors
collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

University of Liverpool

OTHER

lead

Royal Liverpool University Hospital

OTHER_GOV

NCT00261118 - Rituximab in Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter